Skip to content
Vivo Bio Tech logo

Vivo Bio Tech

VIVOBIOT NSE
₹13.50 down 0.37 (2.67%)
Market Cap
₹29.96 Cr

Vivo Bio Tech (VIVOBIOT) share price was ₹13.87 at the 28 Oct 2026 close; market capitalisation ₹30.78 Cr; sector Healthcare. The share price fell 58.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 14.2% year on year to ₹14.28 Cr and net profit fell 85.8% year on year to ₹0.19 Cr (compared with Jun 2025). Promoters held 22.51% of Vivo Bio Tech in Sep 2026, down 8.11 percentage points from Jun 2026. Its Tapetide Score is 40/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹13.87 −19.39 −58.30% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹29.96 Cr
EBITDA
₹21.90 Cr
Return on Equity
-1.83%
Debt to Equity
0.72
Book Value
₹41.25
EPS (TTM)
−₹1.28
52W High
₹35.76
52W Low
₹12.00

Price-based figures as of 29 Oct 2026, 10:36 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Biotechnology

Anthem Biosciences
₹823.8080.3746,423 Cr15.250.24%19.45%26.78%2,161 Cr576 Cr
Advanced Enzyme Tech
₹261.5017.652,907 Cr1.792.05%10.31%13.58%800 Cr172 Cr
CCME Global
₹33.52—152 Cr3.790.00%-0.35%0.87%0 Cr-1 Cr
Vivo Bio Tech (this company)
₹13.50—30 Cr0.330.00%-1.83%7.19%55 Cr-3 Cr
Shree Ganesh Biotech
₹0.45—18 Cr0.280.00%0.59%0.81%7 Cr-0 Cr
Genomic Valley Biotech
₹45.811,527.0014 Cr3.560.00%9.13%11.32%0 Cr0 Cr
Median 6 companies₹39.6780.3791 Cr2.680.00%4.86%9.26%31 Cr-0 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

40 Weak
Overall score

Data confidence 93/100

Category scores

Quality Weak 44
Returns, margins, earnings quality 22% weight
Valuation Good 60
Cheap vs sector & own history 24% weight
Growth Average 54
Sales & profit trajectory 9% weight
Financial Health Poor 20
Solvency, leverage, coverage 9% weight
Momentum Poor 4
Trend strength, vol-adjusted 12% weight
Ownership Poor 35
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.31 times its book value

Weaknesses

5
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -8.11%
  • The company has delivered a poor sales growth of 0.59% over past five years.
  • Promoter holding is low: 22.5%
  • Company has a low return on equity of 1.06% over last 3 years.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
4.47% higher than 3Y

change over 1 year

Net Income Growth
-123% higher than 3Y

change over 1 year

Cash Flow Change
195%

change over 1 year

EBITDA Margin Change
-17.22%

change over 1 year Operating margin 35.36% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
11.58
9.26
12.85
11.76
10.13
12.04
12.21
12.29
12.51
13.11
13.51
14.2
14.28
Expenses
7.09
4.4
6.48
6.39
5.77
6.45
6.67
7.27
7.03
7.69
8.02
9.75
9.23
Operating Profit
4.49
4.86
6.37
5.37
4.36
5.59
5.54
5.02
5.48
5.42
5.49
4.45
5.05
OPM %
38.77%
52.48%
49.57%
45.66%
43.04%
46.43%
45.37%
40.85%
43.8%
41.34%
40.64%
31.34%
35.36%
Other Income
0
0
0.03
0.01
0.01
4.63
0.01
0.15
0.14
0.13
0.14
0.03
0.06
Interest
1.95
2.09
2.22
1.52
1.92
2.06
1.84
1.68
1.5
1.47
1.4
1.48
1.24
Depreciation
2.29
2.3
2.28
2.43
2.23
2.29
2.25
2.25
2.64
2.57
2.66
2.75
3.53
PBT
0.25
0.47
1.9
1.43
0.22
5.87
1.46
1.24
1.48
1.51
1.57
0.25
0.34
Tax %
44%
29.79%
31.05%
48.95%
27.27%
10.73%
43.84%
14.52%
9.46%
42.38%
20.38%
2164%
44.12%
Net Profit
0.14
0.33
1.32
0.74
0.17
5.23
0.82
1.06
1.34
0.87
1.25
-5.16
0.19
EPS (₹)
0.09
0.22
0.89
0.5
0.11
3.51
0.51
0.62
0.67
0.39
0.57
-2.33
0.09
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17.79
28.58
34.13
47
55.83
55.35
51.78
51.39
52.23
45.45
46.67
53.33
55.1
Expenses
14.99
24.87
26.51
36.11
46.32
42.88
33.98
35.3
30.39
24.19
26.11
31.82
34.69
Operating Profit
2.8
3.71
7.62
10.89
9.51
12.47
17.8
16.09
21.84
21.26
20.56
21.51
20.41
OPM %
15.74%
12.98%
22.33%
23.17%
17.03%
22.53%
34.38%
31.31%
41.82%
46.78%
44.05%
40.33%
37.04%
Other Income
0.95
0.89
0.4
0.13
0.01
0.05
0.08
0.1
0.04
0.04
4.8
-0.16
0.36
Interest
0.51
0.47
1.29
2.37
2.64
3.1
3.67
4.27
7.99
7.95
7.55
5.91
5.59
Depreciation
3.05
3.35
3.9
4.64
5.06
5.17
5.59
7.45
9.27
9.29
9.02
10.63
11.51
PBT
0.19
0.78
2.83
4.01
1.82
4.25
8.62
4.47
4.62
4.06
8.79
4.81
3.67
Tax %
-142.11%
-16.67%
11.66%
21.95%
-23.08%
-4.47%
34.11%
50.78%
42.64%
37.93%
17.18%
135.55%
—
Net Profit
0.46
0.91
2.5
3.12
2.25
4.44
5.68
2.2
2.65
2.53
7.28
-1.71
-2.85
EPS (₹)
0.49
0.97
2.67
3.17
1.82
3.45
4.23
1.54
1.78
1.7
4.24
-0.77
-1.28
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9.35
9.35
9.35
9.85
12.35
12.89
13.42
14.26
14.9
14.9
17.16
22.19
Reserves
-0.18
0.71
3.22
9.46
14.92
20.14
29.11
32.87
36.97
39.5
60.74
70.97
Borrowings
5.69
16.91
27.06
25.12
21.68
24.37
30.96
67.44
62.39
73.06
54.02
67.38
Other Liabilities
26.57
18.69
11.49
15.08
6.37
6.29
6.03
7.91
8.77
9.67
11.31
17.89
Total Liabilities
41.43
45.66
51.12
59.51
55.32
63.69
79.52
122
123
137
143
178
Fixed Assets
19.69
23.54
28.57
27.66
30.01
34.99
52.05
95.17
88.87
80.37
88.24
123
CWIP
0.07
0.04
2.96
3.94
0.07
0.15
0.32
0.87
1.9
9.21
12.84
4.81
Investments
0
0
0
0
0
0
0
0
0
0
0
21.91
Other Assets
21.67
22.08
19.59
27.91
25.24
28.55
27.15
26.44
32.26
47.55
42.15
28.68
Total Assets
41.43
45.66
51.12
59.51
55.32
63.69
79.52
122
123
137
143
178
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2.25
8.81
-5.66
11.11
-0.78
8.61
14.18
16.64
14.83
15.52
11.83
34.93
Investing
-2.04
-7.2
-11.84
-4.72
-3.53
-10.23
-22.82
-51.11
-4
-7.95
-15.84
-59.35
Financing
-0.89
-0.32
6.83
-3.43
0.72
2.09
8.78
35.02
-11.18
-7.56
3.9
24.57
Net Cash Flow
-0.68
1.3
-10.67
2.96
-3.59
0.47
0.14
0.55
-0.34
0.01
-0.11
0.15
Free Cash Flow
0.21
1.61
-17.5
6.39
-4.31
-1.62
-8.64
-34.47
10.83
7.57
-4.01
-2.51
CFO/EBITDA
81
234
-70
110
-13
68
96
118
77
80
65
166
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88.43
48.79
82.03
91.48
54.98
69.11
51.39
85.37
86.52
94.76
87.98
80.42
Inventory Days
558
169
204
289
256
451
672
313
430
831
491
366
Days Payable
814
363
242
304
152
167
70.37
74.02
50.68
100
61.78
88
Cash Conversion Cycle
-168
-145
44.36
76.61
159
354
653
324
466
826
517
358
Working Capital Days
-354
-131
19.25
-13.28
36.22
35.15
28.76
8.1
38.09
63.76
100
-22.24
ROCE %
4.67%
5.98%
12.37%
15.18%
9.55%
13.82%
18.78%
9.29%
11.02%
9.94%
9.04%
7.74%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vivo Bio Tech insights

64 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Others44.89%Promot.22.51%Public32.60%As ofSep 2026

Documents

Frequently Asked Questions about Vivo Bio Tech

What does Vivo Bio Tech Ltd do?
Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]
Where is Vivo Bio Tech Ltd (VIVOBIOT) listed?
Vivo Bio Tech Ltd trades as VIVOBIOT on the NSE and under code 511509 on the BSE.
Which sector does Vivo Bio Tech Ltd belong to?
Vivo Bio Tech Ltd is classified under the Healthcare sector, in the Biotechnology industry.
What is the market capitalisation of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd has a market capitalisation of ₹29.96 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Vivo Bio Tech Ltd?
Over the last 52 weeks Vivo Bio Tech Ltd has traded between ₹12 and ₹35.76 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd reported a return on equity of -1.83%. Its debt-to-equity ratio is 0.72.

Company Information

Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]

Website vivobio.com
Listed 2026-08-17
Face Value ₹ 10
Shares Outstanding 2,21,90,628

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/511509.md for Vivo Bio Tech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month